WARRINGTON, Pa., May 3, 2016 /PRNewswire/ -- Windtree
Therapeutics, Inc. (Nasdaq: WINT), a biotechnology
company focused on developing aerosolized KL4 surfactant therapies
for respiratory diseases, will report first quarter 2016
financial results and provide business updates on Thursday, May 12, 2016 before the open of the
U.S. financial markets.
The Company will also host a live teleconference and webcast,
including a slide presentation, at 8:00 a.m. EDT on the same
day to discuss the 2016 first quarter financial results along with
providing other business updates. The live webcast and archive of
the conference call can be accessed at
http://windtreetx.investorroom.com/events.
For "listen-only" participants and those who wish to take part
in the question and answer portion of the call, dial (877) 870-4263
(domestic) or (412) 317-0790 (international). After placing the
call, request to be joined into the Windtree Therapeutics
conference call. A replay of the conference call will be
accessible one hour after completion through May 19, 2016 by dialing (877) 344-7529 (domestic)
or (412) 317-0088 (international) and referencing conference ID
number 10085848.
About Windtree Therapeutics
Windtree Therapeutics, Inc. is a clinical-stage biotechnology
company focused on developing novel surfactant therapies for
respiratory diseases and other potential applications. Windtree's
proprietary technology platform includes a synthetic,
peptide-containing surfactant (KL4 surfactant) that is
structurally similar to endogenous pulmonary surfactant and novel
drug-delivery technologies being developed to enable noninvasive
administration of aerosolized KL4 surfactant. Windtree is
focused initially on improving the management of respiratory
distress syndrome (RDS) in premature infants and believes that its
proprietary technology may make it possible, over time, to develop
a pipeline of KL4 surfactant product candidates to address a
variety of respiratory diseases for which there are few or no
approved therapies.
For more information, please visit the Company's website at
www.windtreetx.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/windtree-therapeutics-to-report-first-quarter-2016-financial-results-and-host-conference-call-on-thursday-may-12-2016-300261946.html
SOURCE Windtree Therapeutics, Inc.